The 2025-2026 Influenza vaccine and the Respiratory Syncytial Virus vaccine (Abrysvo) are now available in our three office locations! Please call the office to schedule your vaccination appointment.
The American College of Obstetricians and Gynecologists (ACOG) strongly recommends that pregnant individuals be vaccinated against Influenza, RSV, and COVID-19.
RSV Vaccine eligibility in pregnancy:
The American College of Obstetricians and Gynecologists recommends a single dose of Pfizer’s bivalent RSVpreF vaccine (Abrysvo) using seasonal administration, to prevent RSV lower respiratory tract infection in infants for eligible pregnant individuals meeting the following criteria:
-are between 32 0/7 and 36 6/7 weeks of gestation,
-do not have a planned delivery within 2 weeks,
-did not receive the maternal RSV vaccine during a previous pregnancy, and
-are not planning to have their infant receive a monoclonal antibody, nirsevimab or clesrovimab.
In most of the continental United States, based on the seasonal circulation of RSV, pregnant patients are eligible to receive the maternal RSV vaccine from September 1 through January 31 to provide protection during the time of circulation of RSV.
It is currently not recommended that pregnant patients who received the maternal RSV vaccine during their last pregnancy receive an additional dose during a subsequent pregnancy. Clinicians should review the patient’s medical record to confirm vaccination status. For patients vaccinated in a previous pregnancy, their infants should receive a monoclonal antibody.